Atlantis Technology Group operates as a development stage company. The company is headquartered in Miami, Florida. On October 22, 2007, the Company signed a letter of intent to purchase a 12.5% interest in Technology Holding Company Intervision Network. On October 25, 2007, the Company signed a letter of intent to purchase a 25% equity interest in a real estate media company. In October 2007, the Company incorporated three Nevada corporations that are its wholly owned subsidiaries. The Companies are Atlantis Media Group, Atlantis Communications Group and Atlantis Energy Corporation.
Atlantis Technology Group の最大収益セグメントは Oral Recombinant Protein Vaccines で、最新の利益発表における収益は 7,379,000 です。地域別に見ると、United States が Atlantis Technology Group の主要市場であり、収益は 7,379,000 です。